Charles Schwab’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $91.6K | Hold |
|
|||||
|
2022
Q3 | $106K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $80K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $44K | Sell |
|
|||||
|
2021
Q1 | $377K | Buy |
|
|||||
|
2020
Q4 | $910K | Buy |
|
|||||
|
2020
Q3 | $686K | Sell |
|
|||||
|
2020
Q2 | $717K | Buy |
|
|||||
|
2020
Q1 | $594K | Buy |
|
|||||
|
2019
Q4 | $474K | Buy |
|
|||||
|
2019
Q3 | $288K | Hold |
|
|||||
|
2019
Q2 | $586K | Buy |
|
|||||
|
2019
Q1 | $558K | Buy |
|
|||||
|
2018
Q4 | $561K | Sell |
|
|||||
|
2018
Q3 | $1.41M | Hold |
|
|||||
|
2018
Q2 | $1.6M | Buy |
|
|||||
|
2018
Q1 | $2.01M | Buy |
|
|||||
|
2017
Q4 | $948K | Buy |
|
|||||
|
2017
Q3 | $474K | Hold |
|
|||||
|
2017
Q2 | $449K | Buy |
|
|||||
|
2017
Q1 | $371K | Hold |
|
|||||
|
2016
Q4 | $224K | Hold |
|
|||||
|
2016
Q3 | $220K | Sell |
|
|||||
|
2016
Q2 | $441K | Hold |
|
|||||
|
2016
Q1 | $536K | Buy |
|
|||||
|
2015
Q4 | $564K | Hold |
|
|||||
|
2015
Q3 | $558K | Buy |
|
|||||
|
2015
Q2 | $324K | Buy |
|